Resultados de la búsqueda 31-40 of 992 for ���������������������������������TALK:PC53���

  1. Mayo Clinic Neurosciences Physician Update — May 2025

    Page 1.

  2. Mayo Clinic Neurosciences Physician Update — July 2025

    Page 1.

  3. Mayo Clinic Pulmonology Physician Update - May 2025

    Page 1.

  4. Mayo Clinic Neurosciences Physician Update — March 2025

    Page 1.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  6. Mayo Clinic Cancer Physician Update - March 2025

    Page 1.

  7. Mayo Clinic Cancer Physician Update - May 2025

    Page 1.

  8. Oncología (médica) - Ensayos clínicos

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers.

  9. Mayo Clinic Physician Update - April 2025

    Page 1.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...